Rachel J. Oidtman
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
COVID-19 epidemiological studies, Mosquito-borne diseases and control, Influenza Virus Research Studies, Pneumonia and Respiratory Infections, Respiratory viral infections research
Most-Cited Works
- → Travel Surveillance and Genomics Uncover a Hidden Zika Outbreak during the Waning Epidemic(2019)106 cited
- → Temperature modulates dengue virus epidemic growth rates through its effects on reproduction numbers and generation intervals(2017)105 cited
- → Estimating unobserved SARS-CoV-2 infections in the United States(2020)94 cited
- → Lying in wait: the resurgence of dengue virus after the Zika epidemic in Brazil(2021)93 cited
- → Inter-annual variation in seasonal dengue epidemics driven by multiple interacting factors in Guangzhou, China(2019)55 cited
- → Trade-offs between individual and ensemble forecasts of an emerging infectious disease(2021)47 cited
- → Influenza immune escape under heterogeneous host immune histories(2021)44 cited
- → COVID-19 reopening strategies at the county level in the face of uncertainty: Multiple Models for Outbreak Decision Support(2020)42 cited
- → Multiple models for outbreak decision support in the face of uncertainty(2023)38 cited
- → Co-circulation and misdiagnosis led to underestimation of the 2015–2017 Zika epidemic in the Americas(2021)36 cited